Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies

by Sandro Matosevic
Published 2018-01-01

Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors

by Andrea M. Chambers, Sandro Matosevic, Sandro Matosevic
Published 2019-07-01

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells

by Andrea M. Chambers, Kyle B. Lupo, Sandro Matosevic, Sandro Matosevic
Published 2018-11-01

163 Nice: neoantigen-cytokine-chemokine multifunctional engager for NK cell immunotherapy of solid tumors

by Sandro Matosevic, Xue Yao
Published 2020-11-01

<i>NT5E</i>/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma

by Jiao Wang, Sandro Matosevic
Published 2019-09-01

CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma

by Kyle B. Lupo, Sandro Matosevic
Published 2020-06-01

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy

by Kyle B. Lupo, Sandro Matosevic
Published 2019-06-01

Adenosinergic Signaling Alters Natural Killer Cell Functional Responses

by Andrea M. Chambers, Jiao Wang, Kyle B. Lupo, Hao Yu, Nadia M. Atallah Lanman, Sandro Matosevic, Sandro Matosevic
Published 2018-10-01

TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation

by Tram N. Dao, Sagar Utturkar, Nadia Atallah Lanman, Sandro Matosevic
Published 2020-08-01

Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

by Jiao Wang, Kyle B. Lupo, Andrea M. Chambers, Sandro Matosevic
Published 2018-12-01

Nanoparticle‐Mediated Intracellular Protection of Natural Killer Cells Avoids Cryoinjury and Retains Potent Antitumor Functions

by Xue Yao, Joshua J. Jovevski, Michaela F. Todd, Rui Xu, Yining Li, Jiao Wang, Sandro Matosevic
Published 2020-05-01